Geron (GERN) Other Non Operating Income (2011 - 2026)
Geron (GERN) posted Other Non Operating Income of -$74000.0 for Q1 2026, down 124.26% sequentially from $305000.0 in Q4 2025, and up 10.84% YoY from -$66760.9 in Q1 2025.
Geron (GERN) Other Non Operating Income (2011 - 2026) Analysis & Trends
Geron has reported Other Non Operating Income for 13 years, with the latest figure at -$74000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 10.84% year-over-year to -$74000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9000.0 (up 100.52% YoY) and the FY2024 annual result came in at -$1.7 million, down 7321.74% from the prior year.
- Other Non Operating Income declined to -$74000.0 in Q1 2026 per GERN's latest filing, from $305000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.1 million in Q2 2022 and troughed at -$1.5 million in Q4 2024.
- A 5-year average of -$47176.5 and a median of -$62000.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income jumped 6629.41% in 2022, then sank 3804.88% in 2024.
- Over 5 years, Other Non Operating Income stood at $86000.0 in 2022, then tumbled by 52.33% to $41000.0 in 2023, then tumbled by 3804.88% to -$1.5 million in 2024, then jumped by 120.08% to $305000.0 in 2025, then sank by 124.26% to -$74000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$74000.0, $305000.0, and -$161000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9,000.00 |
| Mar 31, 2026 | -74,000.00 |
| Dec 31, 2025 | 305,000.00 |
| Sep 30, 2025 | -161,000.00 |
| Jun 30, 2025 | -61,000.00 |
| Mar 31, 2025 | -83,000.00 |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -63,000.00 |
| Jun 30, 2024 | -63,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | -92,000.00 |
| Jun 30, 2023 | -11,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 86,000.00 |
| Sep 30, 2022 | -138,000.00 |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | -56,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | -77,000.00 |